Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 1/2006

01-04-2006 | 2005 IUGA Grafts Roundtable

Pelvic organ prolapse: demographics and future growth prospects

Authors: Harold P. Drutz, May Alarab

Published in: International Urogynecology Journal | Special Issue 1/2006

Login to get access

Abstract

Pelvic Organ Prolapse (POP) is the hidden epidemic. Demographic studies have shown that women over the age of eighty are the fastest growing population segment in the United States and Canada. Over the next thirty years the rate of women who will seek treatment for POP will double. Risks for the development of POP have been categorized into factors that predispose, incite, promote, and decompensate. Connective tissue disorders may play a role in the pathogenesis which may involve a reduction in total collagen content secondary to increased collagenolytic activity. Eventually clinicians may be able to identify women who may be genetically predetermined to develop POP. The role of adjuvant materials in performing reconstructive pelvic surgery may improve success rates, but evidence based medicine and randomized controlled trials are currently lacking.
Literature
1.
Van Meekeren J (1728) Heel- en geneeskonstige aenmerkingen. Alphen aan de Rijn: Stafleu 313–319
2.
Subak LL, Waetjen LE, Van den Eaden S et al (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98:646–651PubMedCrossRef
3.
Olsen AL, Smith VJ, Bergstrom JO et al (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRef
4.
Luber KM, Boero S, Choe JY(2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184:1496–1501PubMedCrossRef
5.
Boyles SH, Weber AM, Meyn L (2003) Procedures for pelvic organ prolapse in the United States, 1979–1997. Am J Obstet Gynecol 188:108–115PubMedCrossRef
6.
Boyles SH, Weber AM, Meyn L (2003) Procedures for urinary incontinence in the United States, 1979–1997. Am J Obstet Gynecol 189:70–75PubMedCrossRef
7.
Swift SE (2000) The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol 183(2):277–285PubMedCrossRef
8.
Hendrix SL, Clark A, Nygaard I et al (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186(6):1160–1166PubMedCrossRef
9.
Burrows LJ, Meyn LA, Walters MD, Weber AM (2004) Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol 104:982–988PubMed
10.
Chou Q, Weber AM, Piedmonte MR (2000) Clinical presentation of enterocele. Obstet Gynecol 96:599–603PubMedCrossRef
11.
Weber AM, Richter HE (2005) Pelvic organ prolapse. Obstet Gynecol 106:615–634PubMed
12.
Sze EH, Sherard GB 3rd, Dolezal JM (2002) Pregnancy, labor, delivery, and pelvic organ prolapse. Obstet Gynecol 100:981–986PubMedCrossRef
13.
O’Boyle Amy L, Woodman Patrick J, O’Boyle John D, Davis Gary D, Swift Steven E (2002) Pelvic organ support in nulliparous pregnant and nonpregnant women: a case control study. Am J Obstet Gynecol 187:99–102PubMedCrossRef
14.
Strohbehn K, Jakary JA, Delancey JO (1997) Pelvic organ prolapse in young women. Obstet Gynecol 90(1):33–36PubMedCrossRef
15.
Lang JH, Zhu L, Sun ZJ, Chen J (2003) Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet 80(1):35–39PubMedCrossRef
16.
Carley ME, Schaffer J (2000) Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers–Danlos syndrome. Am J Obstet Gynecol 182(5):1021–1023PubMedCrossRef
17.
Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996) Changes in metabolism of collagen in genitourinary prolapse. Lancet 347:1658–1661PubMedCrossRef
18.
Wong MY, Harmanli OH, Agar M, Dandolu V, Grody MH (2003) Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol 189(6):1597–1599 (discussion 1599–1600)PubMedCrossRef
19.
Chen BH, Wen Y, Li H, Polan ML (2002) Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct 13(2):80–87PubMedCrossRef
20.
Chen B, Wen Y, Polan ML (2004) Elastolytic activity in women with stress urinary incontinence and pelvic organ prolapse. Neurourol Urodyn 23(2):119–126PubMedCrossRef
21.
Ozdegirmenci O, Karslioglu Y, Dede S, Karadeniz S, Haberal A, Gunhan O, Celasun B (2005) Smooth muscle fraction of the round ligament in women with pelvic organ prolapse: a computer-based morphometric analysis. Int Urogynecol J Pelvic Floor Dysfunct 16(1):39–43PubMedCrossRef
22.
Keane D, Sims TJ, Bailey AJ et al (1992) Analysis of pelvic floor electromyography and collagen status in pre-menopausal nulliparous females with genuine stress incontinence. Neurourol Urodyn 11:308–309
23.
Keane DP, Sims TJ, Abrams P, Bailey AJ (1997) Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 104(9):994–998 SepPubMed
24.
Kushner L, Mathrubutham M, Burney T, Greenwald R, Badlani G (2004) Excretion of collagen derived peptides is increased in women with stress urinary incontinence. Neurourol Urodyn 23(3):198–203PubMedCrossRef
25.
Chen Y, DeSautel M, Anderson A, Badlani G, Kushner L (2004) Collagen synthesis is not altered in women with stress urinary incontinence. Neurourol Urodyn 23(4):367–373PubMedCrossRef
Metadata
Title
Pelvic organ prolapse: demographics and future growth prospects
Authors
Harold P. Drutz
May Alarab
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue Special Issue 1/2006
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-006-0102-1

Other articles of this Special Issue 1/2006

International Urogynecology Journal 1/2006 Go to the issue

2005 IUGA Grafts Roundtable

Biology of polypropylene/polyglactin 910 grafts

2005 IUGA Grafts Roundtable

InteXen tissue processing and laboratory study

2005 IUGA Grafts Roundtable

Clinical implications of the biology of grafts: conclusions of the 2005 IUGA Grafts Roundtable

2005 IUGA Grafts Roundtable

The biology behind fascial defects and the use of implants in pelvic organ prolapse repair

2005 IUGA Grafts Roundtable

Evolution of biological and synthetic grafts in reconstructive pelvic surgery

2005 IUGA GRAFTS ROUNDTABLE

International Urogynecological Association: The Usage of Grafts in Pelvic Reconstructive Surgery Symposium 2005